Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term follow-up of patients receiving boceprevir for treatment of chronic hepatitis C.

Antiviral research - 1 Jan 2015

Howe Anita Y M, Long Jianmin, Nickle David, Barnard Richard, Thompson Seth, Howe John, Alves Katia, Wahl Janice

Abstract excerpt

The durability of sustained virologic response (SVR) following boceprevir-based therapy in patients with hepatitis C virus (HCV) infection has not been reported. Furthermore, in patients receiving protease inhibitor-based therapies, development of resistance can contribute to treatment failure. The aim of the present study was to follow the clinical progression of patients treated with boceprevir after treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Proline

Share to Recurrence

Share to Treatment Failure

Source

Identifiers

PMID: 25446895
DOI: 10.1016/j.antiviral.2014.10.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term follow-up of patients receiving boceprevir for treatment of chronic hepatitis C.PMID 25446895Read ↗

Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up study.Semantic proximity Read ↗

Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.Semantic proximity Read ↗

Sustained virological response after treatment in patients with chronic hepatitis C infection--a five year follow up.Semantic proximity Read ↗

How sustained is sustained viral response in patients with hepatitis C virus infection?Semantic proximity Read ↗

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon.Semantic proximity Read ↗

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin.Semantic proximity Read ↗

Boceprevir: a review of its use in the management of chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection.Semantic proximity Read ↗

Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure.Semantic proximity Read ↗

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.Semantic proximity Read ↗

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical TrialsSemantic proximity Read ↗

Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.